Abbott announced the FDA clearance of its Lingo & Libre Rio CGMs, which are based on ABT's world-leading FreeStyle Libre CGM ... marketing techniques and after sale services can prove beneficial ...

The t:slim X2 pump is currently cleared for use with Humalog and Novolog/NovoRapid U-100 insulins globally, and Admelog/Insulin lispro Sanofi and Trurapi/Insulin aspart Sanofi U-100 insulins in Canada ...

Following this development, t:slim X2 was approved for sale by Canada Health ... system to integrate with Abbott’s new FreeStyle Libre 2 Plus sensor in 2023. The breakthrough development ...

Abbott announced Thursday that its prescription-free continuous glucose monitor, Lingo, is now available for sale in the US ... are based on its popular FreeStyle Libre sensor technology ...

Both of Abbott's over-the-counter CGMS are based on its popular FreeStyle Libre sensor technology, as Dexcom's prescription-free Stelo follows the popular G6 and G7 CGM technology for people who ...

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...

Abbott launched an over-the-counter continuous glucose monitoring system, Lingo, for adults not on insulin -- the second such ...

The company excels in innovation, with standout products like the FreeStyle Libre for diabetes management and its growing portfolio of minimally invasive cardiovascular technologies, including ...

These estimates do not include title, registration fees, lien fees, or any other fees that may be imposed by a governmental agency in connection with the sale and financing of the vehicle.